Recruiting Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors NCT07584499 Conditions Atypical Teratoid/Rhabdoid Tumors, Carcinoma, Carcinoma, Squamous Cell, +53 more Locations Sun Yat-sen University Cancer Center — Guangzhou, Guangdong, China View Trial Details
